Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 500


Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis.

Clute SC, Watkin LB, Cornberg M, Naumov YN, Sullivan JL, Luzuriaga K, Welsh RM, Selin LK.

J Clin Invest. 2005 Dec;115(12):3602-12. Epub 2005 Nov 23.


Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.

Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF.

Arthritis Res. 2000;2(2):154-64. Epub 2000 Feb 7.


Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.

Brain. 2008 Jul;131(Pt 7):1712-21. doi: 10.1093/brain/awn108. Epub 2008 Jun 11.


Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1).

Ouyang Q, Wagner WM, Voehringer D, Wikby A, Klatt T, Walter S, Müller CA, Pircher H, Pawelec G.

Exp Gerontol. 2003 Aug;38(8):911-20.


Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses.

He XS, Mahmood K, Maecker HT, Holmes TH, Kemble GW, Arvin AM, Greenberg HB.

J Infect Dis. 2003 Apr 1;187(7):1075-84. Epub 2003 Mar 19.


Retrovirus-mediated gene transfer in polyclonal T cells results in lower apoptosis and enhanced ex vivo cell expansion of CMV-reactive CD8 T cells as compared with EBV-reactive CD8 T cells.

Sauce D, Rufer N, Mercier P, Bodinier M, Rémy-Martin JP, Duperrier A, Ferrand C, Hervé P, Romero P, Lang F, Tiberghien P, Robinet E.

Blood. 2003 Aug 15;102(4):1241-8. Epub 2003 May 1.


Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.

Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, Pamer EG, Howe JG, Craft J.

J Immunol. 2004 Jan 15;172(2):1287-94.


Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.

Suneetha PV, Schlaphoff V, Wang C, Stegmann KA, Fytili P, Sarin SK, Manns MP, Cornberg M, Wedemeyer H.

J Immunol Methods. 2009 Mar 15;342(1-2):33-48. doi: 10.1016/j.jim.2008.11.020. Epub 2009 Jan 9.


A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.

Tan LC, Gudgeon N, Annels NE, Hansasuta P, O'Callaghan CA, Rowland-Jones S, McMichael AJ, Rickinson AB, Callan MF.

J Immunol. 1999 Feb 1;162(3):1827-35.


IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells.

van Leeuwen EM, de Bree GJ, Remmerswaal EB, Yong SL, Tesselaar K, ten Berge IJ, van Lier RA.

Blood. 2005 Sep 15;106(6):2091-8. Epub 2005 Jun 9.


A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers.

Yu HX, Srinivasan N, Ren EE, Chan SH.

Tissue Antigens. 2005 Jun;65(6):539-43.


Successful in vitro priming of EBV-specific CD8+ T cells endowed with strong cytotoxic function from T cells of EBV-seronegative children.

Comoli P, Ginevri F, Maccario R, Frasson C, Valente U, Basso S, Labirio M, Huang GC, Verrina E, Baldanti F, Perfumo F, Locatelli F.

Am J Transplant. 2006 Sep;6(9):2169-76. Epub 2006 Jun 22.


Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics.

Faint JM, Annels NE, Curnow SJ, Shields P, Pilling D, Hislop AD, Wu L, Akbar AN, Buckley CD, Moss PA, Adams DH, Rickinson AB, Salmon M.

J Immunol. 2001 Jul 1;167(1):212-20.


Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8+ T cells during persistent infection.

Dunne PJ, Belaramani L, Fletcher JM, Fernandez de Mattos S, Lawrenz M, Soares MV, Rustin MH, Lam EW, Salmon M, Akbar AN.

Blood. 2005 Jul 15;106(2):558-65. Epub 2005 Mar 29.


A fractal clonotype distribution in the CD8+ memory T cell repertoire could optimize potential for immune responses.

Naumov YN, Naumova EN, Hogan KT, Selin LK, Gorski J.

J Immunol. 2003 Apr 15;170(8):3994-4001.


Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells.

Vescovini R, Telera A, Fagnoni FF, Biasini C, Medici MC, Valcavi P, di Pede P, Lucchini G, Zanlari L, Passeri G, Zanni F, Chezzi C, Franceschi C, Sansoni P.

Exp Gerontol. 2004 Aug;39(8):1233-43.


Activated lymphocytes during acute Epstein-Barr virus infection.

Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL.

J Immunol. 1987 Dec 1;139(11):3802-7.


Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.

Hammer MH, Brestrich G, Mittenzweig A, Roemhild A, Zwinger S, Subklewe M, Beier C, Kurtz A, Babel N, Volk HD, Reinke P.

J Immunother. 2007 Nov-Dec;30(8):817-24.


Supplemental Content

Support Center